Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yuko Morino"'
Improvement of dyspeptic symptoms after Helicobacter pylori eradication therapy in Japanese patients
Autor:
Eri Iwata, Mitsushige Sugimoto, Masaki Murata, Yuko Morino, Yoshika Akimoto, Mariko Hamada, Ryota Niikura, Naoyoshi Nagata, Takashi Kawai
Publikováno v:
JGH Open, Vol 7, Iss 12, Pp 855-862 (2023)
Abstract Background and Aim Helicobacter pylori eradication therapy effectively improves the abdominal symptoms and bowel habits of patients. Patients in whom dyspepsia is under control by 6 to 12 months after successful H. pylori eradication are def
Externí odkaz:
https://doaj.org/article/3abaa8cfd1e04ac1b149ac68a23b1c3c
Autor:
Mitsushige Sugimoto, Yusuke Kawai, Yuko Morino, Mariko Hamada, Eri Iwata, Ryota Niikura, Naoyoshi Nagata, Yohei Koyama, Masakatsu Fukuzawa, Takao Itoi, Takashi Kawai
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 1004-1013 (2022)
Background A new image-enhanced endoscopy method called texture and colour enhancement imaging (TXI) enhances brightness, surface irregularities, and subtle colour changes in endoscopic images. However, it is unclear whether TXI and narrow-band imagi
Externí odkaz:
https://doaj.org/article/0fb9b1f88fe34cbe847ae77df769cdb9
Autor:
Yuko Morino, Mitsushige Sugimoto, Naoyoshi Nagata, Ryota Niikiura, Eri Iwata, Mariko Hamada, Yusuke Kawai, Tatsuhiro Fujimiya, Hironori Takeuchi, Sakae Unezaki, Takashi Kawai
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Proton pump inhibitors (PPIs) are the first-line treatment for acid-related diseases. The pharmacokinetics and therapeutic efficacy of PPIs, however, are influenced by genetic factors such as variants in genes encoding drug-metabolizing e
Externí odkaz:
https://doaj.org/article/160bc7670a7b47c0ad482b8ec7711b5c
Autor:
Mitsushige Sugimoto, Eri Iwata, Tatsuhiro Fujimiya, Takashi Kawai, Ryota Niikiura, Naoyoshi Nagata, Hironori Takeuchi, Yusuke Kawai, Yuko Morino, Mariko Hamada, Sakae Unezaki
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Background: Proton pump inhibitors (PPIs) are the first-line treatment for acid-related diseases. The pharmacokinetics and therapeutic efficacy of PPIs, however, are influenced by genetic factors such as variants in genes encoding drug-metabolizing e